The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

Patient-generated AI trends reshaping clinical visits guide clinicians to clarify, standardize responses and improve patient communication.

The closest “natural substitute” that aligns with medical advice is to consume a combination of high-fiber foods, lean ...

Physicians are trained to anticipate every negative outcome. But that mindset can follow you home, fueling anxiety and ...

A device you might want with you in an avalanche; why heart failure with preserved ejection fraction may be seen as a ...

A systematic review and meta-analysis finds that weight-loss interventions are associated with decreased psoriasis severity ...

Edward S. Cooper, MD, the American Heart Association’s first Black president, leaves behind an indelible mark on stroke ...

Trial data on epcoritamab plus rituximab-lenalidomide, a novel CELMoD agent, late-line CAR-T cell therapy, and selecting ...

Insights from ASH 2025, including anticipated presentations, key takeaways, and how emerging research in paroxysmal nocturnal ...

Dr Mark Kris breaks down the lazertinib-amivantamab data, noting that the combo shows benefit but fails to address key ...

Dr Suchitra Sundaram reflects on time limited venetoclax combinations, next generation non covalent BTK inhibitors, and novel ...

Chronic myeloid leukemia highlights from ASH 2025 include data on nilotinib vs imatinib, asciminib in second line, somatic ...